Methods of assessing the risk for the development of sporadic prostate cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 23, 2008
Grant Date -
Apr 6, 2006
app pub date -
Nov 22, 2005
filing date -
Mar 24, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention concerns the genomic sequence of the purH gene. The invention also concerns biallelic markers of a purH gene and the association established between these markers and cancer, particularly prostate cancer. The invention provides means to determine the predisposition of individuals to cancer as well as means for the diagnosis of cancer and for the prognosis/detection of an eventual treatment response to agents acting on cancer.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully